Zhao L, Zhao W, Hou Y, Wen C, Wang J, Wu P, Guo Z (2020) An overview of managements in meningiomas. Front Oncol 10:1523. https://doi.org/10.3389/fonc.2020.01523
Article PubMed PubMed Central Google Scholar
Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro-oncology 23:1821–1834. https://doi.org/10.1093/neuonc/noab150
CAS Article PubMed PubMed Central Google Scholar
Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M et al (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383–e391. https://doi.org/10.1016/s1470-2045(16)30321-7
Islim AI, Mohan M, Moon RDC, Srikandarajah N, Mills SJ, Brodbelt AR, Jenkinson MD (2019) Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes. J Neurooncol 142:211–221. https://doi.org/10.1007/s11060-019-03104-3
CAS Article PubMed PubMed Central Google Scholar
Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J et al (2019) DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-oncology 21:901–910. https://doi.org/10.1093/neuonc/noz061
CAS Article PubMed PubMed Central Google Scholar
Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682–694. https://doi.org/10.1016/S1470-2045(17)30155-9
CAS Article PubMed Google Scholar
Euskirchen P, Peyre M (2018) Management of meningioma. La Presse Médicale 47:e245–e252. https://doi.org/10.1016/j.lpm.2018.05.016
Cui M, Wang H, Yao X, Zhang D, Xie Y, Cui R, Zhang X (2019) Circulating microRNAs in cancer: potential and challenge. Front Genet 10:626
Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6:259–269. https://doi.org/10.1038/nrc1840
CAS Article PubMed Google Scholar
Chen X, Liang H, Zen K, Zhang C-Y (2016) Secreted microRNAs from tumor cells can suppress immune function. Oncoimmunology 5:e982407
Chen X, Liang H, Zhang J, Zen K, Zhang C-Y (2012) Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22:125–132
Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26:462
Nik Mohamed Kamal NNSB, Shahidan WNS (2020) Non-exosomal and exosomal circulatory microRNAs: which are more valid as biomarkers? Front Pharmacol 10:1500
Yang G, Xiong G, Cao Z, Zheng S, You L, Zhang T, Zhao Y (2016) miR-497 expression, function and clinical application in cancer. Oncotarget 7:55900–55911. https://doi.org/10.18632/oncotarget.10152
Article PubMed PubMed Central Google Scholar
Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14:2348–2360. https://doi.org/10.1261/rna.1034808
CAS Article PubMed PubMed Central Google Scholar
Liu Z, Wu S, Wang L, Kang S, Zhao B, He F, Liu X, Zeng Y, Liu J (2019) Prognostic value of microRNA-497 in various cancers: a systematic review and meta-analysis. Dis mark 2019:2491291–2491291. https://doi.org/10.1155/2019/2491291
Özata DM, Caramuta S, Velázquez-Fernández D, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C, Lui W-O (2011) The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer 18:643–655. https://doi.org/10.1530/ERC-11-0082
CAS Article PubMed PubMed Central Google Scholar
Xu J-W, Wang T-X, You L, Zheng L-F, Shu H, Zhang T-P, Zhao Y-P (2014) Insulin-like growth factor 1 receptor (IGF-1R) as a target of miR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer. PLoS ONE 9:e92847. https://doi.org/10.1371/journal.pone.0092847
CAS Article PubMed PubMed Central Google Scholar
Itesako T, Seki N, Yoshino H, Chiyomaru T, Yamasaki T, Hidaka H, Yonezawa T, Nohata N, Kinoshita T, Nakagawa M et al (2014) The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster. PLoS ONE 9:e84311. https://doi.org/10.1371/journal.pone.0084311
CAS Article PubMed PubMed Central Google Scholar
Wang S, Mo Y, Midorikawa K, Zhang Z, Huang G, Ma N, Zhao W, Hiraku Y, Oikawa S, Murata M (2015) The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L. Oncotarget 6(2015):35893–35907. https://doi.org/10.18632/oncotarget.5651
Article PubMed PubMed Central Google Scholar
Shen L, Li J, Xu L, Ma J, Li H, Xiao X, Zhao J, Fang L (2012) miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. Exp Ther Med 3:475–480. https://doi.org/10.3892/etm.2011.428
CAS Article PubMed Google Scholar
Li W, Jin X, Deng X, Zhang G, Zhang B, Ma L (2014) The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. Biochem Biophys Res Commun 449:235–240. https://doi.org/10.1016/j.bbrc.2014.05.011
CAS Article PubMed Google Scholar
Yan J-J, Zhang Y-N, Liao J-Z, Ke K-P, Chang Y, Li P-Y, Wang M, Lin J-S, He X-X (2015) miR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Oncotarget 6:29527–29542. https://doi.org/10.18632/oncotarget.5012
Article PubMed PubMed Central Google Scholar
Wang W, Ren F, Wu Q, Jiang D, Li H, Shi H (2014) MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the Pi3k/Akt and MAPK/ERK pathways in ovarian cancer. Oncol Rep 32:2127–2133. https://doi.org/10.3892/or.2014.3439
CAS Article PubMed Google Scholar
Wei C, Luo Q, Sun X, Li D, Song H, Li X, Song J, Hua K, Fang L (2015) MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer. Int J Clin Exp Pathol 8:7729–7739
CAS PubMed PubMed Central Google Scholar
Wang L, Li B, Li L, Wang T (2013) MicroRNA-497 suppresses proliferation and induces apoptosis in prostate cancer cells. Asian Pac J Cancer Prev 14:3499–3502. https://doi.org/10.7314/apjcp.2013.14.6.3499
Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, Smolsky M, Kim RY, Saria MG, Pastorino S, Kesari S (2012) MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro-oncology 14:689–700
López-Aguilar JE, Velázquez-Flores MA, Simón-Martínez LA, Ávila-Miranda R, Rodríguez-Florido MA, Garrido RR-E (2017) Circulating microRNAs as biomarkers for pediatric astrocytomas. Arch Med Res 48:323–332
Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J (2016) Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. J Neurosurg 124:122–128
Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G et al (2016) A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. J Exp Clin Cancer Res 35:124. https://doi.org/10.1186/s13046-016-0393-0
CAS Article PubMed PubMed Central Google Scholar
Negroni C, Hilton DA, Ercolano E, Adams CL, Kurian KM, Baiz D, Hanemann CO (2020) GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma. EBioMedicine 59:102941. https://doi.org/10.1016/j.ebiom.2020.102941
CAS Article PubMed PubMed Central Google Scholar
Zhi F, Shao N, Li B, Xue L, Deng D, Xu Y, Lan Q, Peng Y, Yang Y (2016) A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma. Sci Rep 6:32067. https://doi.org/10.1038/srep32067
CAS Article PubMed PubMed Central Google Scholar
Schageman J, Zeringer E, Li M, Barta T, Lea K, Gu J, Magdaleno S, Setterquist R, Vlassov AV (2013) The complete exosome workflow solution: from isolation to characterization of RNA cargo. Biomed Res Int 2013:253957. https://doi.org/10.1155/2013/253957
CAS Article PubMed PubMed Central Google Scholar
Adams CL, Ercolano E, Ferluga S, Sofela A, Dave F, Negroni C, Kurian KM, Hilton DA, Hanemann CO (2020) A rapid robust method for subgrouping non-NF2 meningiomas according to genotype and detection of lower levels of M2 macrophages in AKT1 E17K mutated tumours. Int J Mol Sci. https://doi.org/10.3390/ijms21041273
Article PubMed PubMed Central Google Scholar
Madadi S, Soleimani M (2019) Comparison of miR-16 and cel-miR-39 as reference controls for serum miRNA normalization in colorectal cancer. J Cell Biochem 120:4802–4803. https://doi.org/10.1002/jcb.28174
CAS Article PubMed Google Scholar
Wang L, Chen S, Liu Y, Zhang H, Ren N, Ma R, He Z (2020) The biological and diagnos
留言 (0)